{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:15:16Z","timestamp":1780402516999,"version":"3.54.1"},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>Malignant mesothelioma (<jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content>) incidence is increasing drastically worldwide as an occupational disease resulting from asbestos exposure. However, no curative treatment for <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content> of advanced stage is available. Thus, new therapeutic approaches for <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content> are required. Because malignant pleural mesothelioma (<jats:styled-content style=\"fixed-case\">MPM<\/jats:styled-content>) cells spread along the pleural surface in most patients, <jats:styled-content style=\"fixed-case\">MPM<\/jats:styled-content> can be targeted using intrapleural therapeutic approaches. In this study, we investigated the effectiveness of the intrapleural instillation of a replication\u2010competent adenovirus as an oncolytic agent against <jats:styled-content style=\"fixed-case\">MPM<\/jats:styled-content>. We constructed a vascular endothelial growth factor promoter\u2010based conditionally replicative adenovirus (<jats:styled-content style=\"fixed-case\">VEGF<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">CRA<\/jats:styled-content>d) that replicates exclusively in <jats:styled-content style=\"fixed-case\">VEGF<\/jats:styled-content>\u2010expressing cells. All of the <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content> cell lines that we tested expressed <jats:styled-content style=\"fixed-case\">VEGF mRNA<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">VEGF<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">CRA<\/jats:styled-content>d selectively replicated in these <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content> cells and exerted a direct concentration\u2010dependent oncolytic effect <jats:italic>in vitro<\/jats:italic>. Furthermore, our <jats:italic>in vivo<\/jats:italic> studies showed that pre\u2010infection of <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content> cells with <jats:styled-content style=\"fixed-case\">VEGF<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">CRA<\/jats:styled-content>d potently suppressed <jats:styled-content style=\"fixed-case\">MPM<\/jats:styled-content> tumor formation in nude mice, and that intrapleural instillation of <jats:styled-content style=\"fixed-case\">VEGF<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">CRA<\/jats:styled-content>d prolonged the survival time of tumor\u2010bearing mice. Our results indicate that <jats:styled-content style=\"fixed-case\">VEGF<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">CRA<\/jats:styled-content>d exerts an oncolytic effect on <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content> cells and that intrapleural instillation of <jats:styled-content style=\"fixed-case\">VEGF<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">CRA<\/jats:styled-content>d is safe and might represent a promising therapeutic strategy for <jats:styled-content style=\"fixed-case\">MPM<\/jats:styled-content>.<\/jats:p>","DOI":"10.1111\/cas.13112","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T11:48:49Z","timestamp":1480592929000},"page":"116-123","source":"Crossref","is-referenced-by-count":3,"title":["Vascular endothelial growth factor promoter\u2010based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesothelioma"],"prefix":"10.1111","volume":"108","author":[{"given":"Akiko","family":"Harada","sequence":"first","affiliation":[{"name":"Research Institute for Diseases of the Chest Graduate School of Medical Sciences Kyushu University Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Uchino","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine Fukuoka University School of Medicine Fukuoka Japan"},{"name":"Department of Pulmonary Medicine Kyoto Prefectural University of Medicine Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishi","family":"Harada","sequence":"additional","affiliation":[{"name":"Research Institute for Diseases of the Chest Graduate School of Medical Sciences Kyushu University Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Nakagaki","sequence":"additional","affiliation":[{"name":"Research Institute for Diseases of the Chest Graduate School of Medical Sciences Kyushu University Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Hisasue","sequence":"additional","affiliation":[{"name":"Research Institute for Diseases of the Chest Graduate School of Medical Sciences Kyushu University Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine Fukuoka University School of Medicine Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Takayama","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine Kyoto Prefectural University of Medicine Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.11.086678"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.2486\/indhealth.MS1184"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408440903044928"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31815608d9"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31816fca1b"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.19594"},{"key":"e_1_2_6_8_1","first-page":"515","article-title":"Angiogenesis inhibition as a therapeutic strategy in non\u2010small cell lung cancer (NSCLC)","volume":"4","author":"Hall RD","year":"2015","journal-title":"Transl Lung Cancer Res"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22006"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000029460"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.824"},{"key":"e_1_2_6_12_1","first-page":"964","article-title":"Pleural mesothelial cells in pleural and lung diseases","volume":"7","author":"Batra H","year":"2015","journal-title":"J Thorac Dis"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31823f45c1"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10996"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2012.681641"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01238-6"},{"key":"e_1_2_6_17_1","first-page":"182","article-title":"Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma","volume":"3","author":"Zhang W","year":"2015","journal-title":"Ann Transl Med"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/572609"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.06.003"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.07.097"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12267"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.plasmid.2014.10.005"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700991"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(68)90121-9"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.11.7498-7509.1996"},{"key":"e_1_2_6_26_1","first-page":"1411","article-title":"Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer","volume":"2","author":"Ohta Y","year":"1996","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_27_1","first-page":"7882","article-title":"A midkine promoter\u2010based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging","volume":"61","author":"Adachi Y","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_6_28_1","first-page":"2169","article-title":"Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ","volume":"60","author":"Takayama K","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-1123-3"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/med.20238"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1996.7.18-2225"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2013.823420"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1994.5.7-821"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0194-75"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1089\/104303401750298535"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1998.9.14-2121"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700269"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcas.13112","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cas.13112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T07:35:29Z","timestamp":1745998529000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cas.13112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1111\/cas.13112"],"URL":"https:\/\/doi.org\/10.1111\/cas.13112","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}